Concepedia

Jan Drappatz

JD

Statistics

Publications

99

Citations

9.8K

H-Index

50

Active since

1999

Affiliations

Center for Neuro-Oncology(Current)

Dana-Farber Cancer Institute

Dana-Farber Brigham Cancer Center

Brigham and Women's Hospital

Harvard University

Jan Drappatz is an author at Center for Neuro-Oncology specializing in oncology, medicine, and brain tumors.

ORCID

Publications per year

1999–2025

99

Publications

99

AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients

Tracy T. Batchelor, A. Gregory Sorensen, Emmanuelle di Tomaso et al. · Cancer Cell · 2007 · 1.8K citations · Full text

, , +17

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Michael Weller, Nicholas Butowski, David Tran et al. · The Lancet Oncology · 2017 · 1.1K citations

, , +13

Phase II Study of Cediranib, an Oral Pan–Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent Glioblastoma

Tracy T. Batchelor, Dan G. Duda, Emmanuelle di Tomaso et al. · Journal of Clinical Oncology · 2010 · 516 citations · Full text

, , +17

Differential Sensitivity of Glioma- versus Lung Cancer–Specific EGFR Mutations to EGFR Kinase Inhibitors

Igor Vivanco, H. Ian Robins, Daniel Rohle et al. · Cancer Discovery · 2012 · 344 citations · Full text

, , +16

Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma

Thomas Kaley, Patrick Y. Wen, David Schiff et al. · Neuro-Oncology · 2014 · 289 citations · Full text

, , +16

1–5 of 99